NCT01144637 A Trial to Evaluate Immunogenicity and Safety of Three Consecutive Production Lots of IMVAMUNE® (MVA-BN®) Smallpox Vaccine in Healthy, Vaccinia-naïve Subjects Status COMPLETED Phase PHASE3
NCT01056770 Safety and Efficacy of CJ Smallpox Vaccine in Healthy Volunteers Status COMPLETED Phase PHASE3
NCT00998543 A Long-Term Study of Healthy Adults Vaccinated With One Dose of Smallpox Vaccine (LISTER Strain) Status COMPLETED Phase N/A
NCT00928577 Safety Surveillance Cohort Study of Vaccinia Vaccine (ACAM2000®) Status COMPLETED Phase N/A
NCT00914732 Lyophilized IMVAMUNE® (1x10^8 TCID50) Versus Liquid IMVAMUNE® (1x10^8 TCID50) Administered Subcutaneously and a Lower Dose Liquid IMVAMUNE® (2x10^7 TCID50) Administered Intradermally Status COMPLETED Phase PHASE2
NCT00857493 A Study to Evaluate Safety and Immunogenicity of One and Two Doses of IMVAMUNE® Smallpox Vaccine in 56-80 Year Old Vaccinia-experienced Subjects Status COMPLETED Phase PHASE2
NCT00686582 An Open-Label Phase II Study to Evaluate Immunogenicity and Safety of a Single IMVAMUNE Booster Vaccination Two Years After the Last IMVAMUNE Vaccination in Former POX-MVA-005 Vaccinees Status COMPLETED Phase PHASE2
NCT00646152 Poly-ICLC to Prevent Respiratory Viral Infections A Safety Study Status COMPLETED Phase PHASE1
NCT00607243 Safety and Efficacy of CJ-50300 in Healthy Volunteers Status COMPLETED Phase PHASE2/PHASE3
NCT00466245 Phase 2 Study of Safety, Tolerability, and Immunogenicity of Three Dose Levels of ACAM3000 Smallpox Vaccine Status COMPLETED Phase PHASE2
NCT00437021 MVA Post-Event: Administration Timing and Boost Study Status COMPLETED Phase PHASE1/PHASE2
NCT00389103 Safety Study of MVA Smallpox Vaccine in Subjects With a History of Atopic Dermatitis (AD) Status WITHDRAWN Phase PHASE1
NCT00316524 A Randomized, Double-blind, Placebo-controlled Study on Immunogenicity and Safety of MVA-BN (IMVAMUNE™) Smallpox Vaccine in Healthy Subjects Status COMPLETED Phase PHASE2
NCT00282581 Safety Study of MVA Smallpox Vaccine in HIV-positive Subjects Who Are Vaccinia Naive Status TERMINATED Phase PHASE1
NCT00258947 Evaluation of Take and Safety of a Smallpox Vaccine in Healthy Young Adults Status COMPLETED Phase PHASE2
NCT00189969 Take Rate, Immunogenicity and Safety of Elstree-BN Smallpox Vaccine in Healthy Vaccinia-Naive Subjects Status COMPLETED Phase PHASE1